Add-on Acquisition • Medical Products

QuidelOrtho Acquires Ortho Clinical Diagnostics

On December 23, 2021, QuidelOrtho acquired medical products company Ortho Clinical Diagnostics for 6.0B USD

Acquisition Context

This is QuidelOrtho’s 1st transaction in the Medical Products sector.
This is QuidelOrtho’s largest (disclosed) transaction.
This is QuidelOrtho’s 4th transaction in the United States.
This is QuidelOrtho’s 1st transaction in New Jersey.

Explore All 2731 Add-on Acquisition Medical Products Deals - Search the Database Free

M&A Deal Summary
Date	December 23, 2021
Target	Ortho Clinical Diagnostics
Sector	Medical Products
Buyer(s)	QuidelOrtho
Deal Type	Add-on Acquisition
Deal Value	6.0B USD
Advisor(s)	J.P. Morgan Securities (Financial) Latham & Watkins (Legal)

Target Company

Ortho Clinical Diagnostics

Raritan, New Jersey, United States

Ortho Clinical Diagnostics is a provider of vitro diagnostic products. The company serves the global transfusion medicine community with donor screening and blood typing products to help ensure every patient receives blood that is safe, the right type and the right unit. Ortho Clinical Diagnostics was founded in 1939 and is based in Raritan, New Jersey.

Explore More Deals

Browse All 215,156 Deals

FILTER BY

Buyer Type (PE or Strategic)
Deal Size ($10M to $10B+)
Sector (60 Sectors)
Deal Type
Geography
& More

Search Free

Buyer Overview 1

Buyer

QuidelOrtho

San Diego, California, United States

Category	Company
Founded	1979
Sector	Healthcare Services
Employees	7,100
Revenue	2.8B USD (2024)

DESCRIPTION

QuidelOrtho develops, manufactures, and markets diagnostic testing solutions for applications in infectious diseases, women?s health, and gastrointestinal diseases. QuidelOrtho was founded in 1979 and is based in San Diego, California.

Deal Context for Buyer	#
Overall	4 of 4
Sector: Medical Products	1 of 1
Type: Add-on Acquisition	2 of 2
State: New Jersey	1 of 1
Country: United States	4 of 4
Year: 2021	1 of 1
Size (of disclosed)	1 of 3

PREVIOUS DEAL

DATE	TARGET	DEAL TYPE	VALUE
2017-07-17	Alere - Triage Assets Waltham, Massachusetts, United States Alere, Inc. - Triage Assets includes MeterPro cardiovascular (CV) and toxicology assets (“Triage business”) and the B-type Naturietic Peptide (BNP) assay business run on Beckman Coulter analyzers (“BNP business”).	Buy	-

DATE

TARGET

DEAL TYPE

VALUE

2017-07-17

Alere - Triage Assets

Waltham, Massachusetts, United States

Alere, Inc. - Triage Assets includes MeterPro cardiovascular (CV) and toxicology assets (“Triage business”) and the B-type Naturietic Peptide (BNP) assay business run on Beckman Coulter analyzers (“BNP business”).

Buy

Explore Related M&A Activity

Medical Products M&A - Add-on Acquisition M&A Deals - New Jersey M&A - United States M&A - 2021 M&A